Supriya Lifescience Limited (IN:SUPRIYA)
:SUPRIYA
Want to see IN:SUPRIYA full AI Analyst Report?
Total Valuation
Supriya Lifescience Limited has a market cap or net worth of ₹75.34B. The enterprise value is ₹77.23B.
Market Cap₹75.34B
Enterprise Value₹77.23B
Share Statistics
Supriya Lifescience Limited has 80,482,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding80,482,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Supriya Lifescience Limited’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 16.35%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)16.35%
Return on Capital Employed (ROCE)0.21
Revenue Per Employee18.48M
Profits Per Employee4.67M
Employee Count448
Asset Turnover0.61
Inventory Turnover2.38
Valuation Ratios
The current PE Ratio of Supriya Lifescience Limited is 36.1. Supriya Lifescience Limited’s PEG ratio is 1.92.
PE Ratio36.1
PS Ratio5.46
PB Ratio3.78
Price to Fair Value3.78
Price to FCF105.21
Price to Operating Cash Flow135.76
PEG Ratio1.92
Income Statement
In the last 12 months, Supriya Lifescience Limited had revenue of 8.28B and earned 2.09B in profits. Earnings per share was 25.98.
Revenue8.28B
Gross Profit4.49B
Operating Income2.66B
Pretax Income2.75B
Net Income2.09B
EBITDA2.66B
Earnings Per Share (EPS)25.98
Cash Flow
In the last 12 months, operating cash flow was 555.65M and capital expenditures -422.49M, giving a free cash flow of 133.16M billion.
Operating Cash Flow555.65M
Free Cash Flow133.16M
Free Cash Flow per Share1.65
Dividends & Yields
Supriya Lifescience Limited pays an annual dividend of ₹1, resulting in a dividend yield of 0.13%
Dividend Per Share₹1
Dividend Yield0.13%
Payout Ratio4.85%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.24
52-Week Price Change33.96%
50-Day Moving Average730.02
200-Day Moving Average710.27
Relative Strength Index (RSI)62.55
Average Volume (3m)18.01K
Important Dates
Supriya Lifescience Limited upcoming earnings date is Aug 10, 2026, Before Open (Confirmed).
Last Earnings DateMay 27, 2026
Next Earnings DateAug 10, 2026
Ex-Dividend Date―
Financial Position
Supriya Lifescience Limited as a current ratio of 4.40, with Debt / Equity ratio of 0.45%
Current Ratio4.40
Quick Ratio3.08
Debt to Market Cap0.00
Net Debt to EBITDA-0.28
Interest Coverage Ratio140.62
Taxes
In the past 12 months, Supriya Lifescience Limited has paid 656.59M in taxes.
Income Tax656.59M
Effective Tax Rate0.24
Enterprise Valuation
Supriya Lifescience Limited EV to EBITDA ratio is 16.75, with an EV/FCF ratio of 103.50.
EV to Sales5.37
EV to EBITDA16.75
EV to Free Cash Flow103.50
EV to Operating Cash Flow22.79
Balance Sheet
Supriya Lifescience Limited has ₹1.06B in cash and marketable securities with ₹52.32M in debt, giving a net cash position of ₹1.01B billion.
Cash & Marketable Securities₹1.06B
Total Debt₹52.32M
Net Cash₹1.01B
Net Cash Per Share₹12.55
Tangible Book Value Per Share₹148.80
Margins
Gross margin is 65.29%, with operating margin of 32.09%, and net profit margin of 25.26%.
Gross Margin65.29%
Operating Margin32.09%
Pretax Margin33.19%
Net Profit Margin25.26%
EBITDA Margin32.09%
EBIT Margin32.09%
Analyst Forecast
The average price target for Supriya Lifescience Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast18.86%
EPS Growth Forecast11.25%